Abstract
In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
